CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

MoonLake Immunotherapeutics submits sonelokimab BLA

BLA FilingsonelokimabPositive
AI Analysis

Summary

MoonLake Immunotherapeutics submitted a BLA for sonelokimab, a therapeutic candidate in development. The submission represents progress toward potential regulatory approval.

Importance:6/10
Sentiment:
0.50
BLA submissionregulatory filingimmunotherapy

Read the original article

Published by Seeking Alpha Healthcare on September 30, 2026 9:48 PM

Read Original